Orbite Technologies Inc. (TSX: ORT), a Canadian cleantech stock, jumped after providing a progress update
Sean Mason | January 23, 2017 | SmallCapPower
An update from a Canadian cleantech company was a breath of fresh air for its shareholders Monday. Here’s some small stocks making big moves on Monday, January 23, 2017 (as of 4 pm EST):
Orbite Technologies Inc. (TSX: ORT) shares surged 30% to $0.345 on Monday after the Canadian cleantech company provided an update on its progress with the production of high purity alumina, which included the receipt of its first two commercial purchase orders for the supply of high purity alumina.
As well, shares of Aptose Biosciences Inc. (TSX: APS) sank 18% to $1.40 as the clinical-stage biotech company said it will temporarily delay clinical activities with APTO-253, a Phase 1 stage compound for acute myeloid leukemia, in order to elucidate the cause of recent manufacturing setbacks related to the intravenous formulation of APTO-253, with the intention of restoring the molecule to a state supporting clinical development and partnering.
Cordoba Minerals Corp. (TSXV: CDB), meanwhile, reported that drilling at the San Matias Copper-Gold Project in Colombia has intersected what the Company called “bonanza gold veins” at Alacran, which included 4,440 g/t gold, 10.25% copper, 24.7% zinc, and 347 g/t silver over 0.9 meters. Cordoba Minerals stock popped 39% to $1.29 following the announcement.
Finally, Balmoral Resources Ltd. (TSX: BAR) shares gained 28% to $0.95 after the gold junior announced drill results on the Bug South gold deposit on its Martiniere Property in Quebec, which included 41.95 metres grading 3.24 g/t gold.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
